Raloxifene (Evista) for breast cancer prevention in postmenopausal women

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2006年 / 48卷 / 1234期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [1] A Review of the Prevention of Invasive Breast Cancer with Raloxifene in Postmenopausal Women
    Arango, Belisario A.
    Castrellon, Aurelio B.
    Santos, Edgardo S.
    Gluck, Stefan
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1173 - 1178
  • [2] Continuing outcomes relevant to evista: Breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene
    Martino, S
    Cauley, JA
    Barrett-Connor, E
    Powles, TJ
    Mershon, J
    Disch, D
    Secrest, RJ
    Cummings, SR
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (23) : 1751 - 1761
  • [3] Re: Continuing Outcomes Relevant to Evista: Breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene - Response
    Martino, S
    Cauley, JA
    Barrett-Connor, E
    Powles, TJ
    Mershon, J
    Disch, D
    Secrest, RJ
    Cummings, SR
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (07) : 542 - 543
  • [4] Combined estrogen blockade of the breast with raloxifene and exemestane in postmenopausal women for breast cancer prevention.
    Dickler, MN
    Robson, ME
    Heerdt, A
    Dang, C
    Lake, D
    Moasser, M
    Bloch, R
    Ballon, DJ
    Morris, EA
    Tan, LK
    Panageas, K
    Norton, L
    Hudis, CA
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 226 - 226
  • [5] Tamoxifen or raloxifene in postmenopausal women for prevention of breast cancer: A tale of two choices-counterpoint
    Fabian, Carol
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (11) : 2210 - 2212
  • [6] Role of raloxifene in breast cancer prevention in postmenopausal women: Clinical evidence and potential mechanisms of action
    Sporn, MB
    Dowsett, SA
    Mershon, J
    Bryant, HU
    CLINICAL THERAPEUTICS, 2004, 26 (06) : 830 - 840
  • [7] Effects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women
    Barrett-Connor, E.
    Mosca, L.
    Collins, P.
    CURRENT CARDIOVASCULAR RISK REPORTS, 2007, 1 (02) : 133 - 136
  • [8] Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women
    Barrett-Connor, Elizabeth
    Mosca, Lori
    Collins, Peter
    Geiger, Mary Jane
    Grady, Deborah
    Kornitzer, Marcel
    McNabb, Michelle A.
    Wenger, Nanette K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (02): : 125 - 137
  • [9] Raloxifene hydrochloride for breast cancer risk reduction in postmenopausal women
    Provinciali, Nicoletta
    Suen, Chen
    Dunn, Barbara K.
    DeCensi, Andrea
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (10) : 1263 - 1272
  • [10] Effect of raloxifene on incidence of invasive breast cancer in postmenopausal women stratified by baseline serum estradiol:: results of the Continuing Outcomes Relevant to Evista® (CORE) trial
    Martino, S
    Powles, T
    Cauley, J
    Mershon, J
    Disch, D
    Secrest, R
    Cummings, S
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S14 - S14
12345